Postgraduate Program in Health Sciences and Technologies, University of Brasília, Brasília, DF, Brazil.
UCIBIO-Applied Molecular Biosciences Unit, i4HB-Institute for Health and Bioeconomy, Laboratory of Pharmacology, Faculty of Pharmacy, University of Porto, Porto, Portugal.
Int J Clin Pharm. 2024 Jun;46(3):602-613. doi: 10.1007/s11096-024-01717-x. Epub 2024 Apr 3.
Key performance indicators (KPIs) are quantifiable measures used to monitor the quality of health services. Implementation guidelines for clinical pharmacy services (CPS) do not specify KPIs.
To assess the quality of the studies that have developed KPIs for CPS in inpatient hospital settings.
A systematic review was conducted by searching in Web of Science, Scopus, and PubMed, supplemented with citation analyses and grey literature searches, to retrieve studies addressing the development of KPIs in CPS for hospital inpatients. Exclusions comprised drug- or disease-specific studies and those not written in English, French, Portuguese, or Spanish. The Appraisal of Indicators through Research and Evaluation (AIRE) instrument assessed methodological quality. Domain scores and an overall score were calculated using an equal-weight principle. KPIs were classified into structure, process, and outcome categories. The protocol is available at https://doi.org/10.17605/OSF.IO/KS2G3 .
We included thirteen studies that collectively developed 225 KPIs. Merely five studies scored over 50% on the AIRE instrument, with domains #3 (scientific evidence) and #4 (formulation and usage) displaying low scores. Among the KPIs, 8.4% were classified as structure, 85.8% as process, and 5.8% as outcome indicators. The overall methodological quality did not exhibit a clear association with a major focus on outcomes. None of the studies provided benchmarking reference values.
The KPIs formulated for evaluating CPS in hospital settings primarily comprised process measures, predominantly suggested by pharmacists, with inadequate evidence support, lacked piloting or validation, and consequently, were devoid of benchmarking reference values.
关键绩效指标(KPI)是用于监测卫生服务质量的可量化措施。临床药学服务(CPS)实施指南并未指定 KPI。
评估为住院患者制定 CPS 关键绩效指标的研究的质量。
通过在 Web of Science、Scopus 和 PubMed 中进行系统检索,并辅以引文分析和灰色文献检索,检索了关于为住院患者制定 CPS 关键绩效指标的研究。排除了药物特异性或疾病特异性研究以及非英文、法语、葡萄牙语或西班牙语撰写的研究。应用研究和评估指标评估(AIRE)工具评估方法学质量。使用等权重原则计算领域得分和总体得分。将 KPI 分为结构、过程和结果类别。方案可在 https://doi.org/10.17605/OSF.IO/KS2G3 获得。
我们纳入了 13 项研究,这些研究共制定了 225 项 KPI。仅有 5 项研究在 AIRE 工具上的得分超过 50%,其中#3(科学证据)和#4(制定和使用)领域得分较低。在 KPI 中,8.4%被归类为结构指标,85.8%为过程指标,5.8%为结果指标。总体方法学质量与主要关注结果之间没有明显的关联。没有研究提供基准参考值。
为评估医院环境中的 CPS 而制定的 KPI 主要由过程指标组成,主要由药剂师提出,证据支持不足,缺乏试点或验证,因此缺乏基准参考值。